Creation of a Pediatric Reference Database for the Kerpape-Rennes-EMG-Based Gait Index
KER-EGI-Kids
1 other identifier
interventional
110
1 country
1
Brief Summary
Brief Summary This prospective, monocentric national study aims to establish normative reference data for the Ker-EGI (Kerpape Gait Index), a novel gait quantification index based on muscle activation profiles of the lower limbs in children. The objective is to determine both the mean activation profile and its variability in a healthy pediatric population. Participants are healthy children and adolescents, aged 3 to 15 years, recruited outside of the Kerpape Rehabilitation Center and specifically attending the Kerpape gait laboratory for this study. A total of 120 subjects are expected. Each participant and their parent(s)/legal guardian provide informed consent prior to enrollment. Study Procedure: Each child is accompanied by at least one parent and participates in a single session lasting approximately one hour. After skin preparation (shaving if necessary and cleaning with alcohol), 28 surface electrodes (ECG type) are placed bilaterally on seven lower limb muscles (tibialis anterior, soleus, gastrocnemius medialis, rectus femoris, vastus medialis, semitendinosus, and gluteus medius). Anatomical landmarks are marked with a dermographic pencil. For younger children, a doll is used to facilitate explanation of electrode placement. The gait analysis is performed with the child in underwear from the time of electrode placement. Each participant completes 10 walking trials (five round trips of 10 meters) at self-selected comfortable speed, following demonstration or a test trial if necessary. Gait is recorded using synchronized cameras and video recordings are anonymized daily. Data Collection: Collected data include participant demographics (name, age, sex, height, weight, leg length), electrode signals, and video recordings. Following the session, electrodes are removed, and children are invited to get dressed. Constraints and Risks: The study involves a minimal deviation from routine conditions: a single one-hour session including electrode placement, walking assessment, and filming. No invasive procedures or therapeutic interventions are conducted. Sample Size: 120 healthy children and adolescents, aged 3 to 15 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy-volunteers
Started Apr 2024
Typical duration for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2025
CompletedFirst Submitted
Initial submission to the registry
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedMarch 27, 2026
March 1, 2026
1.4 years
October 1, 2025
March 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Normative Kerpape Gait Index-Kids (Ker-EGI Kids) in children
Establishment of a reference database for the Ker-EGI Kids, a gait quantification index based on lower limb muscle activation profiles in children aged 3 to 15 years. The primary outcome is the mean Ker-EGI Kids profile and its variability, with a maximum margin of error of 10%.
Single session per participant (~1 hour)
Study Arms (1)
Healthy children and adolescents (3-15 years) undergoing gait analysis
EXPERIMENTALInterventions
Each participant undergoes a standardized gait analysis session. After skin preparation, 28 surface electrodes are placed bilaterally on seven lower limb muscles. The child completes 10 walking trials (five round trips of 10 meters) at a comfortable, self-selected speed while being recorded by synchronized cameras. Data collected include Electromyography signals and video recordings. This procedure is non-invasive and performed in a single session lasting approximately one hour
Eligibility Criteria
You may qualify if:
- Child/adolescent aged 3 to 15 years who has given assent, and whose parents (or legal representative) have provided consent to participate in this study.
- Affiliation with a social security system or beneficiary of such a system.
You may not qualify if:
- Any known pathology affecting gait pattern (lower limbs, upper limbs, or spine).
- History of orthopedic surgery.
- Behavioral disorder incompatible with data collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
Ploemeur, 56270, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2025
First Posted
October 8, 2025
Study Start
April 17, 2024
Primary Completion
August 29, 2025
Study Completion
August 29, 2025
Last Updated
March 27, 2026
Record last verified: 2026-03